Welcome to LookChem.com Sign In|Join Free

CAS

  • or
5-methyl-3-nitrobenzene-1,2-diol is an organic compound with the molecular formula C7H7NO4. It is a yellow crystalline solid that is soluble in water and various organic solvents. 5-methyl-3-nitrobenzene-1,2-diol is characterized by the presence of a methyl group (-CH3) at the 5th carbon position, a nitro group (-NO2) at the 3rd carbon position, and two hydroxyl groups (-OH) at the 1st and 2nd carbon positions on a benzene ring. Due to its unique structure, 5-methyl-3-nitrobenzene-1,2-diol exhibits various chemical properties and can be used in the synthesis of pharmaceuticals, dyes, and other chemical products. It is important to handle 5-methyl-3-nitrobenzene-1,2-diol with care, as it may have potential health and environmental hazards.

89791-96-8

Post Buying Request

89791-96-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

89791-96-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 89791-96-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,9,7,9 and 1 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 89791-96:
(7*8)+(6*9)+(5*7)+(4*9)+(3*1)+(2*9)+(1*6)=208
208 % 10 = 8
So 89791-96-8 is a valid CAS Registry Number.

89791-96-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-methyl-3-nitrobenzene-1,2-diol

1.2 Other means of identification

Product number -
Other names 5-methyl-3-nitro-pyrocatechol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:89791-96-8 SDS

89791-96-8Relevant articles and documents

Gas-phase IR cross-sections and single crystal structures data for atmospheric relevant nitrocatechols

Arsene, Cecilia,Bejan, Iustinian-Gabriel,Olariu, Romeo-Iulian,Roman, Claudiu,Roman, Tiberiu

, (2021/09/28)

The gas-phase IR absorption cross sections for 3-nitrocatechol, 5-methyl-3-nitrocatechol, 4-nitrocatechol and 4-methyl-5-nitrocatechol were evaluated using the ESC-Q-UAIC (the environmental simulation chamber made of quartz from the “Alexandru Ioan Cuza” University of Iasi, Romania) photoreactor facilities. Specific infrared absorptions and integrated band intensities in the range of 650–4000 cm?1 were investigated by long path gas-phase FT-IR technique. Two different addition methods (solid and liquid transfer methods) of nitrocatechols into the reactor were employed in these investigations. All investigated nitrocatechols were synthesized and characterized by X-ray diffraction spectroscopy techniques beside traditional nuclear magnetic resonance (NMR) and infrared (IR) spectroscopy in order to evaluate their structure-properties relationship in gas and solid phase. This study reports for the first time the gas-phase infrared cross sections and the X-ray diffraction analysis for (methyl) nitrocatechols.

Pyrimidine derivatives Anaplastic lymphoma kinase inhibitors

-

, (2018/07/30)

The invention belongs to the technical filed of medicines, and concretely relates to pyrimidine derivative anaplastic lymphoma kinase inhibitors represented by general formula (I), or stereoisomers, or pharmaceutically acceptable salts or esters or solvat

POLYCYCLIC ANAPLASTIC LYMPHOMA KINASE INHIBITOR

-

, (2018/02/06)

Provided is a polycyclic inhibitor of anaplastic lymphoma kinase as represented by Formula (I), or a pharmaceutically acceptable salt or stereoisomer thereof, wherein R1, R2, R3, R4, and ring A are as defined in the description. The invention also relates to a method for preparing the compound, a pharmaceutical preparation and a pharmaceutical composition comprising the compound, and use of the compound, the pharmaceutically acceptable salt or stereoisomer thereof in manufacture of a medicament for the treatment and/or prevention of an anaplastic lymphoma kinase-mediated cancer or non-cancer related diseases.

Triazine derivative anaplastic lymphoma kinase inhibitor

-

, (2017/01/02)

The invention belongs to the technical field of medicines, and particularly relates to a triazine derivative anaplastic lymphoma kinase inhibitor shown in a general formula (I), pharmaceutically acceptable salt, ester, solvate or stereoisomer of the inhibitor. R1, R2, R3, R4, R6, R7 and A rings are defined in the description. The invention further relates to a preparation method of compounds, a medicinal preparation containing the compounds, a medicine combination containing the compounds and an application of the compounds, the pharmaceutically acceptable salt, ester, solvate or stereoisomer to preparation of a medicine for treating and/or preventing anaplastic lymphoma kinase-mediated cancer-related diseases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 89791-96-8